Trial intelligence / Profile preview

Weekly Isotretinoin for Moderate Acne

NCT04594759Phase 2Completed

Sponsor
Medical University of South Carolina
Start
Nov 2020
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of isotretinoin in acne vulgaris, sponsored by Medical University of South Carolina. Started Nov 2020; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT04594759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04594759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call